Lower-Cost Weight Loss Injections UK 2026: NHS Access, Service Fees and Provider Checks
Lower-cost weight loss injections UK guide: how to compare private consultation service fees, NHS eligibility, follow-up costs and provider safety checks without public prescription-medicine price tables.
Important context
Healthcare prices can change without notice and may exclude consultation fees, medication, diagnostics, anaesthetic, facility fees, follow-up care or add-ons. TreatCompare summarises published or compiled pricing for comparison and planning only. Always verify the current total directly before paying.
- Source type
- Named public and provider sources
- Primary source
- MHRA: Advertising of medicines (Blue Guide)
- Reporting period
- 2026-05-20
- Last updated
- 2026-05-20
- Figure type
- Mixed sources
- Use
- Research and comparison only
Are you a clinic, provider or data owner?
If you believe information on this page is inaccurate, out of date, incomplete or presented without necessary context, contact us with the page URL and supporting evidence. We review correction requests promptly, but they are not automatically accepted.
How this guide was checked
TreatCompare uses published provider fees, official regulator registers, NHS/PBS/Medicare references where relevant, and the methodology described on our methodology page. If a clinic, provider or reader spots information that is out of date, they can use our corrections page. Prices are point-in-time and can change before booking.
Most useful next step
Compare current Weight Loss options
This guide explains the UK service-cost framework. Continue to provider checks, NHS eligibility and medicine patient information without public prescription-medicine prices.
Continue from this guide
Turn this Weight Loss article into a comparison
Article visitors often need one of three routes next: provider checks, NHS eligibility, or a related medicine information page.
Important information for UK consumers. This guide explains the service-cost framework around private weight-management consultations. It does not list prescription-medicine prices, rank named prescription medicines by price, or replace advice from a UK-registered prescriber.
Lower-cost route: the practical answer
Lower-cost route checklist
Use this checklist before paying for a private weight-management consultation:
| Check | Why it matters |
|---|---|
| NHS eligibility | NHS-funded access may be lower-cost if you meet current criteria and local access is available. |
| Consultation fee | Some providers charge separately for the initial assessment; others bundle it into a programme fee. |
| Prescribing and dispensing | Ask which UK-registered prescriber assesses you and which GPhC-registered pharmacy dispenses. |
| Follow-up reviews | Ongoing monitoring may be included, billed separately or required before each prescription. |
| Blood tests and measurements | Some pathways need blood tests, blood pressure, weight evidence or specialist review. |
| Delivery and cold chain | Ask whether refrigerated delivery, sharps bins and missed-delivery handling are included. |
| Cancellation terms | Monthly programmes can differ on minimum commitment, pause rules and refund policy. |
Why we compare service fees, not medicine prices
Mounjaro, Wegovy, Ozempic and other GLP-1 weight-management medicines are prescription-only medicines in the UK. Public brand-by-price tables can cross into prescription-medicine advertising. TreatCompare therefore compares the service route: who assesses you, how follow-up works, what is included, and whether NHS access is realistic before you pay privately.
For the broader service-cost framework, see Weight Loss Injection Cost UK.
NHS access before private payment
NHS access is decided through NICE guidance, NHS England rollout cohorts and local pathways. Before paying privately, check whether your BMI, ethnicity-adjusted BMI threshold and health conditions put you into an eligible group.
- NHS weight-loss injection eligibility checker
- Mounjaro patient information
- Wegovy patient information
Private provider questions
Ask every provider these questions in writing:
- Is the initial consultation included or separate?
- Is prescribing, dispensing and delivery bundled into the advertised service fee?
- Who is the prescriber, and which pharmacy dispenses?
- How often are follow-up reviews required?
- Are blood tests, sharps bins or dietitian appointments separate?
- What happens if the prescriber decides treatment is not clinically appropriate?
- Can you take the clinical plan to your GP or another provider?
Healthcare data note
Sources, review and limits
Main sources
- TreatCompare compiled research and provider-published information
Methodology: This guide explains service-level cost components and NHS-access checks for UK weight-management consultations. It does not display prescription-medicine prices, pair medicine brands with prices, rank providers by medicine price, or replace prescriber assessment.
Compare next
Frequently asked questions
How do I find a lower-cost route for weight loss injections in the UK?
Start by checking NHS eligibility, then compare private service fees rather than public medicine prices: consultation, prescribing, dispensing, delivery, follow-up reviews, blood tests and cancellation terms. The medicine price is provided by the dispensing pharmacy after a clinical assessment.
Why does TreatCompare not rank Mounjaro, Wegovy or Ozempic by price?
Mounjaro, Wegovy and Ozempic are prescription-only medicines. UK rules restrict public advertising of prescription medicines, so TreatCompare does not publish brand-by-price tables, rank named medicines by price or list provider-by-medicine offers.
Can NHS treatment be lower-cost than private treatment?
Yes, if you qualify and local access is available. NHS eligibility depends on NICE guidance, NHS England rollout cohorts and local pathway availability. In England, the NHS prescription charge may apply; prescriptions are free in Scotland, Wales and Northern Ireland.
What private service fees should I compare?
Compare the consultation fee, prescribing or clinical-assessment fee, dispensing and delivery charges, follow-up review fees, blood-test costs, sharps-bin costs and any monthly programme fee.
Sources & further reading
- MHRA: Advertising of medicines (Blue Guide) — UK regulator guidance on advertising prescription-only medicines to the public.
- NICE TA1026: Tirzepatide for managing overweight and obesity — NHS commissioning criteria for tirzepatide.
- NICE TA875: Semaglutide for managing overweight and obesity — NHS commissioning criteria for semaglutide 2.4mg.
- General Pharmaceutical Council — Register for checking UK pharmacy and pharmacist status.
Continue with UK weight-loss cost guidance
Weight Loss Injection Cost UK
Service-cost framework, NHS eligibility, provider checks and patient information for Mounjaro, Wegovy, Ozempic and Nevolat queries.
Lower-Cost Injection Route
NHS access, service fees and provider checks
Mounjaro Price UK Questions
Service fees, NHS access and provider checks
Wegovy Price UK Questions
Service fees, NHS access and dose context
Mounjaro Patient Information
Tirzepatide doses, safety checks and prescriber questions
Wegovy Patient Information
Semaglutide 2.4mg doses, safety checks and NHS route
Related articles
GLP-1 Weight-Management Medicines in the UK: Patient Information (2026)
Patient information about the GLP-1 receptor agonists used for weight management or type 2 diabetes in the UK — Mounjaro, Wegovy, Ozempic, Rybelsus, Nevolat. No prescription-medicine prices.
How to Get Mounjaro in the UK: Patient Information (2026)
Patient information about UK NHS and private routes for Mounjaro (tirzepatide). Not an advertisement and not medical advice.
Mounjaro Price UK 2026: Cost Questions, NHS Access and Provider Checks
Mounjaro price UK guide: why prescription-medicine prices are not displayed, what private service fees to ask about, NHS access and GPhC provider checks.
Mounjaro Maintenance Dose in the UK: Patient Information
General patient information about the Mounjaro (tirzepatide) maintenance-dose phase in the UK. Not an advertisement and not medical advice.